Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Intramyocardial injection of skeletal myoblasts: long-term follow-up with pressure–volume loops

Abstract

The human heart has a limited capacity for self-repair because, unlike most other cells, cardiomyocytes do not regenerate. Therefore, if a substantial number of myocytes is lost after a myocardial infarction, the performance of the heart may become severely limited, leading to a condition of heart failure. Recently, cell transplantation has emerged as a potential therapy for patients with end-stage heart failure. Of the various cell types being investigated for this purpose, skeletal myoblasts are an attractive option, because they are readily available from muscle biopsies and, if autologous cells are used, immunosuppression is not required and ethical issues are avoided. Several studies have shown that the cells can survive and differentiate after transplantation, and promising clinical results have been reported. However, effects of this therapy on left ventricular function remain largely unknown. In the present study, we investigated the long-term hemodynamic effects of intramyocardial injection of autologous skeletal myoblasts in patients with ischemic heart failure. Our findings indicate hemodynamic improvement after follow-up for up to 1 year, which is especially promising in view of the expected decline in left ventricular function in these patients.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Steady-state pressure–volume loops (A), end-systolic pressure–volume relationship (ESPVR) and end-diastolic pressure–volume relationship (EDPVR) (B), for each patient

Similar content being viewed by others

References

  1. Tambara K et al. (2003) Transplanted skeletal myoblasts can fully replace the infarcted myocardium when they survive in the host in large numbers. Circulation 108 (Suppl 1): II259–II263

    PubMed  Google Scholar 

  2. Taylor DA et al. (1998) Regenerating functional myocardium: improved performance after skeletal myoblast transplantation. Nat Med 4: 929–933

    Article  CAS  Google Scholar 

  3. Jain M et al. (2001) Cell therapy attenuates deleterious ventricular remodeling and improves cardiac performance after myocardial infarction. Circulation 103: 1920–1927

    Article  CAS  Google Scholar 

  4. Ghostine S et al. (2002) Long-term efficacy of myoblast transplantation on regional structure and function after myocardial infarction. Circulation 106 (Suppl 1): I131–I136

    PubMed  Google Scholar 

  5. Thompson RB et al. (2003) Comparison of intracardiac cell transplantation: autologous skeletal myoblasts versus bone marrow cells. Circulation 108 (Suppl 1): II264–II271

    PubMed  Google Scholar 

  6. Murtuza B et al. (2004) Transplantation of skeletal myoblasts secreting an IL-1 inhibitor modulates adverse remodeling in infarcted murine myocardium. Proc Natl Acad Sci USA 101: 4216–4221

    Article  CAS  Google Scholar 

  7. Agbulut O et al. (2004) Comparison of human skeletal myoblasts and bone marrow-derived CD133+ progenitors for the repair of infarcted myocardium. J Am Coll Cardiol 44: 458–463

    Article  CAS  Google Scholar 

  8. Quaini F et al. (2002) Chimerism of the transplanted heart. N Engl J Med 346: 5–15

    Article  Google Scholar 

  9. Leobon B et al. (2003) Myoblasts transplanted into rat infarcted myocardium are functionally isolated from their host. Proc Natl Acad Sci USA 100: 7808–7811

    Article  CAS  Google Scholar 

  10. Rubart M et al. (2004) Spontaneous and evoked intracellular calcium transients in donor-derived myocytes following intracardiac myoblast transplantation. J Clin Invest 114: 775–783

    Article  CAS  Google Scholar 

  11. Hagège AA et al. (2001) Regeneration of the myocardium: a new role in the treatment of ischemic heart disease? Hypertension 38: 1413–1415

    Article  Google Scholar 

  12. Pagani FD et al. (2003) Autologous skeletal myoblasts transplanted to ischemia-damaged myocardium in humans: histological analysis of cell survival and differentiation. J Am Coll Cardiol 41: 879–888

    Article  Google Scholar 

  13. Smits PC et al. (2003) Catheter-based intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischemic heart failure: clinical experience with six-month follow-up. J Am Coll Cardiol 42: 2063–2069

    Article  Google Scholar 

  14. Menasché P et al. (2003) Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J Am Coll Cardiol 41: 1078–1083

    Article  Google Scholar 

  15. Siminiak T et al. (2004) Autologous skeletal myoblast transplantation for the treatment of postinfarction myocardial injury: phase I clinical study with 12 months of follow-up. Am Heart J 148: 531–537

    Article  Google Scholar 

  16. Makkar RR et al. (2003) Stem cell therapy for myocardial repair: is it arrhythmogenic? J Am Coll Cardiol 42: 2070–2072

    Article  Google Scholar 

  17. Herreros J et al. (2003) Autologous intramyocardial injection of cultured skeletal muscle-derived stem cells in patients with non-acute myocardial infarction. Eur Heart J 24: 2012–2020

    Article  Google Scholar 

  18. Criteria Committee of the New York Heart Association. (1994) Nomenclature and Criteria for Diagnosis of Diseases of the Heart and Great Vessels, edn 9, 253–256. Boston: Little, Brown.

  19. Baan J et al. (1984) Continuous measurement of left ventricular volume in animals and humans by conductance catheter. Circulation 70: 812–823

    Article  CAS  Google Scholar 

  20. Steendijk P et al. (2001) Hypertonic saline method accurately determines parallel conductance for dual-field conductance catheter. Am J Physiol Heart Circ Physiol 281: H755–H763

    Article  CAS  Google Scholar 

  21. Kass DA et al. (1988) Use of a conductance (volume) catheter and transient inferior vena caval occlusion for rapid determination of pressure-volume relationships in man. Cathet Cardiovasc Diagn 15: 192–202

    Article  CAS  Google Scholar 

  22. Steendijk P et al. (1998) Effects of critical coronary stenosis on global systolic left ventricular function quantified by pressure-volume relations during dobutamine stress in the canine heart. J Am Coll Cardiol 32: 816–826

    Article  CAS  Google Scholar 

  23. Glower DD et al. (1985) Linearity of the Frank-Starling relationship in the intact heart: the concept of preload recruitable stroke work. Circulation 71: 994–1009

    Article  CAS  Google Scholar 

  24. Little WC et al. (1989) Comparison of measures of left ventricular contractile performance derived from pressure-volume loops in conscious dogs. Circulation 80: 1378–1387

    Article  CAS  Google Scholar 

  25. Menasché P (2004) Cellular transplantation: hurdles remaining before widespread clinical use. Curr Opin Cardiol 19: 154–161

    Article  Google Scholar 

  26. Muller-Ehmsen J et al. (2002) Cellular cardiomyoplasty—a novel approach to treat heart disease. Congest Heart Fail 8: 220–227

    Article  Google Scholar 

  27. Menasché P (2003) Skeletal muscle satellite cell transplantation. Cardiovasc Res 58: 351–357

    Article  Google Scholar 

  28. Koh GY et al. (1993) Differentiation and long-term survival of C2C12 myoblast grafts in heart. J Clin Invest 92: 1548–1554

    Article  CAS  Google Scholar 

  29. Hagège AA et al. (2003) Viability and differentiation of autologous skeletal myoblast grafts in ischaemic cardiomyopathy. Lancet 361: 491–492

    Article  Google Scholar 

  30. Dowell JD et al. (2003) Myocyte and myogenic stem cell transplantation in the heart. Cardiovasc Res 58: 336–350

    Article  CAS  Google Scholar 

  31. Menasché P (2005) Skeletal myoblast for cell therapy. Coron Artery Dis 16: 105–110

    Article  Google Scholar 

  32. Chachques JC et al. (2004) Autologous human serum for cell culture avoids the implantation of cardioverter-defibrillators in cellular cardiomyoplasty. Int J Cardiol 95 (Suppl 1): S29–S33

    Article  Google Scholar 

  33. Scorsin M et al. (2000) Comparison of the effects of fetal cardiomyocyte and skeletal myoblast transplantation on postinfarction left ventricular function. J Thorac Cardiovasc Surg 119: 1169–1175

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The study was supported by Bioheart Inc., Weston, FL, USA.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Paul Steendijk.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Steendijk, P., Smits, P., Valgimigli, M. et al. Intramyocardial injection of skeletal myoblasts: long-term follow-up with pressure–volume loops. Nat Rev Cardiol 3 (Suppl 1), S94–S100 (2006). https://doi.org/10.1038/ncpcardio0416

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpcardio0416

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing